GULLUNI, Federico
Dettaglio
GULLUNI, Federico
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Pubblicazioni
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
51 | Autoregulation of Class II Alpha PI3K Activity by Its Lipid-Binding PX-C2 Domain Module | 2018 | Wang H.; Lo W.-T.; Vujicic Zagar A.; Gulluni F.; Lehmann M.; Scapozza L.; Haucke V.; Vadas O. |
52 | Class II PI3K Functions in Cell Biology and Disease | 2019 | Gulluni, Federico; De Santis, Maria Chiara; Margaria, Jean Piero; Martini, Miriam; Hirsch, Emilio* |
53 | Cytokinetic abscission: Phosphoinositides and ESCRTs direct the final cut | 2017 | Gulluni, Federico; Martini, Miriam; Hirsch, Emilio |
54 | Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth | 2019 | Cisse O.; Quraishi M.; Gulluni F.; Guffanti F.; Mavrommati I.; Suthanthirakumaran M.; Oh L.C.R.; Schlatter J.N.; Sarvananthan A.; Broggini M.; Hirsch E.; Falasca M.; Maffucci T. |
55 | In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes | 2015 | Li Chew, C.; Lunardi, A.; Gulluni, F.; Ruan, D. T.; Chen, M.; Salmena, L.; Nishino, M.; Papa, A.; Ng, C.; Fung, J.; Clohessy, J. G.; Sasaki, J.; Sasaki, T.; Bronson, R. T.; Hirsch, E.; Pandolfi, P. P. |
56 | Methods to measure the enzymatic activity of PI3Ks. | 2014 | Ciraolo E;Gulluni F;Hirsch E |
57 | Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function | 2017 | Gulluni, Federico; Martini, Miriam; De Santis, Maria Chiara; Campa, Carlo Cosimo; Ghigo, Alessandra; Margaria, Jean Piero; Ciraolo, Elisa; Franco, Irene; Ala, Ugo; Annaratone, Laura; Disalvatore, Davide; Bertalot, Giovanni; Viale, Giuseppe; Noatynska, Anna; Compagno, Mara; Sigismund, Sara; Montemurro, Filippo; Thelen, Marcus; Fan, Fan; Meraldi, Patrick; Marchiò, Caterina; Pece, Salvatore; Sapino, Anna; Chiarle, Roberto; Di Fiore, Pier Paolo; Hirsch, Emilio |
58 | Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction | 2019 | Tiosano D.; Baris H.N.; Chen A.; Hitzert M.M.; Schueler M.; Gulluni F.; Wiesener A.; Bergua A.; Mory A.; Copeland B.; Gleeson J.G.; Rump P.; van Meer H.; Sival D.A.; Haucke V.; Kriwinsky J.; Knaup K.X.; Reis A.; Hauer N.N.; Hirsch E.; Roepman R.; Pfundt R.; Thiel C.T.; Wiesener M.S.; Aslanyan M.G.; Buchner D.A. |
59 | Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation | 2016 | Franco, Irene; Margaria, Jean Piero; De Santis, Maria Chiara; Ranghino, Andrea; Monteyne, Daniel; Chiaravalli, Marco; Pema, Monika; Campa, Carlo Cosimo; Ratto, Edoardo; Gulluni, Federico; Perez-Morga, David; Somlo, Stefan; Merlo, Giorgio R; Boletta, Alessandra; Hirsch, Emilio |
60 | Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast Cancer | 2022 | Li H.; Prever L.; Hsu M.Y.; Lo W.-T.; Margaria J.P.; De Santis M.C.; Zanini C.; Forni M.; Novelli F.; Pece S.; Di Fiore P.P.; Porporato P.E.; Martini M.; Belabed H.; Nazare M.; Haucke V.; Gulluni F.; Hirsch E. |
61 | Phosphoinositides in cell proliferation and metabolism | 2020 | Hirsch E.; Gulluni F.; Martini M. |
62 | PI(3,4)P2 Signaling in Cancer and Metabolism | 2020 | Gozzelino L.; De Santis M.C.; Gulluni F.; Hirsch E.; Martini M. |
63 | PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation | 2021 | Gulluni F.; Prever L.; Li H.; Krafcikova P.; Corrado I.; Lo W.-T.; Margaria J.P.; Chen A.; de Santis M.C.; Cnudde S.J.; Fogerty J.; Yuan A.; Massarotti A.; Sarijalo N.T.; Vadas O.; Williams R.L.; Thelen M.; Powell D.R.; Schueler M.; Wiesener M.S.; Balla T.; Baris H.N.; Tiosano D.; McDermott B.M.; Perkins B.D.; Ghigo A.; Martini M.; Haucke V.; Boura E.; Merlo G.R.; Buchner D.A.; Hirsch E. |
64 | PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. | 2014 | Franco I;Gulluni F;Campa CC;Costa C;Margaria JP;Ciraolo E;Martini M;Monteyne D;De Luca E;Germena G;Posor Y;Maffucci T;Marengo S;Haucke V;Falasca M;Perez-Morga D;Boletta A;Merlo GR;Hirsch E |
65 | PI3K/AKT signaling pathway and cancer: an updated review. | 2014 | Martini M;De Santis MC;Braccini L;Gulluni F;Hirsch E |
66 | Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. | 2013 | Posor Y;Eichhorn-Gruenig M;Puchkov D;Schöneberg J;Ullrich A;Lampe A;Müller R;Zarbakhsh S;Gulluni F;Hirsch E;Krauss M;Schultz C;Schmoranzer J;Noé F;Haucke V |
67 | Structural basis of phosphatidylinositol 3-kinase C2α function | 2022 | Lo W.-T.; Zhang Y.; Vadas O.; Roske Y.; Gulluni F.; De Santis M.C.; Zagar A.V.; Stephanowitz H.; Hirsch E.; Liu F.; Daumke O.; Kudryashev M.; Haucke V. |
68 | Targeting PI3K in Cancer: Any Good News? | 2013 | Miriam Martini;Elisa Ciraolo;Federico Gulluni;Emilio Hirsch |
69 | Targeting PI3K signaling in cancer: Challenges and advances | 2019 | De Santis M.C.; Gulluni F.; Campa C.C.; Martini M.; Hirsch E. |
70 | Targeting pi3k/akt/mtor signaling pathway in breast cancer | 2021 | Li H.; Prever L.; Hirsch E.; Gulluni F. |